GSK says it will appeal a US court ruling allowing more than 70,000 lawsuits to go forward, amid disputed claims its heartburn drug Zantac has links to cancer. The FTSE 100 drugmaker told investors on Monday it will 'immediately seek an appeal' following Delaware judge Vivian Medinilla's decision, adding that the firm will 'vigorously defend itself against all claims'. On Friday, Judge Medinilla ruled that scientific experts will be granted permission to present the case that GSK's drug Zantac may cause cancer. Many retail giants, including Walgreens and Walmart, began withdrawing Zantac from the shelves in 2019 due to cancer fears. Valadez had alleged that her cancer was a result of taking over-the-counter Zantac and generic versions of it from 1995 to 2014.

Source: Daily Mail June 03, 2024 22:55 UTC